Abstract
1628P Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Preliminary results from a multi-cohort, multi-center phase II trial (ALTER-G-001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have